Evercore ISI initiated coverage on shares of argenx (NASDAQ:ARGX – Free Report) in a research note issued to investors on Monday, Marketbeat.com reports. The firm issued an outperform rating and a $436.00 price target on the stock. A number of other equities analysts also recently weighed in on the stock. Truist Financial increased their price […]
By Sabela Ojea Argenx said Monday that it is offering $750 million of ordinary shares. The biotechnology company said the offering will be comprised of.
argenx SE (NASDAQ:ARGX – Get Rating) – William Blair raised their Q2 2023 earnings per share (EPS) estimates for argenx in a report issued on Thursday, June 22nd. William Blair analyst M. Minter now expects that the company will post earnings of ($2.56) per share for the quarter, up from their previous estimate of ($2.98). […]
argenx (NASDAQ:ARGX – Get Rating) had its price target increased by Jefferies Financial Group from $455.00 to $465.00 in a research report report published on Wednesday, The Fly reports. A number of other research firms also recently weighed in on ARGX. Robert W. Baird raised shares of argenx from a neutral rating to an outperform […]
By Stephen Nakrosis Argenx said Tuesday it received Food and Drug Administration approval for its Vyvgart Hytrulo injection to treat certain adult patients.